Literature DB >> 1385767

Kinetics of cytokine secretion by mononuclear cells of the blood from rheumatoid arthritis patients are different from those of healthy controls.

S Ruschen1, W Stellberg, H Warnatz.   

Abstract

Mononuclear cells from peripheral blood (PBMC) of rheumatoid arthritis (RA) patients and healthy controls were incubated with alpha-CD3. Cytokine secretion from 2 h to 72 h of incubation was measured by ELISA. There were no significant differences in secretion of T cell derived IL-2 and IL-4 in cultures from RA patients and controls. The macrophage-derived cytokines, IL-1 beta and tumour-necrosis factor-alpha (TNF-alpha) were secreted with a steep increase of concentration during the first 16 h of incubation by PBMC from RA patients. PBMC from healthy controls secreted both cytokines at a constantly rising rate with a maximum for TNF-alpha at 48 h and for IL-1 beta at 72 h. Interferon-gamma (IFN-gamma) is secreted in significantly reduced concentrations by PBMC from untreated RA patients compared with controls. Gold-salt treatment led to a slightly delayed and enhanced secretion of TNF-alpha and IL-1 beta, an enhanced secretion of IL-2 and a restored secretion of IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1385767      PMCID: PMC1554400          DOI: 10.1111/j.1365-2249.1992.tb06873.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  49 in total

Review 1.  Native interleukin 1 inhibitors.

Authors:  J W Larrick
Journal:  Immunol Today       Date:  1989-02

Review 2.  Immunogenetic and cellular immune mechanisms in rheumatoid arthritis: relevance to new therapeutic strategies.

Authors:  G Kingsley; C Pitzalis; G S Panayi
Journal:  Br J Rheumatol       Date:  1990-02

Review 3.  [Interleukin-1 in the pathogenesis of chronic polyarthritis].

Authors:  H Warnatz; S Ruschen; G Lemm
Journal:  Med Klin (Munich)       Date:  1990-05-15

4.  Characteristics of tumor necrosis factor production in rheumatoid arthritis.

Authors:  D E Yocum; L Esparza; S Dubry; J B Benjamin; R Volz; P Scuderi
Journal:  Cell Immunol       Date:  1989-08       Impact factor: 4.868

5.  Detection of transforming growth factor-beta in rheumatoid arthritis synovial tissue: lack of effect on spontaneous cytokine production in joint cell cultures.

Authors:  F M Brennan; D Chantry; M Turner; B Foxwell; R Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

6.  Spontaneous and LPS-stimulated production of intracellular IL-1 beta by synovial macrophages in rheumatoid arthritis is inhibited by IFN-gamma.

Authors:  S Ruschen; G Lemm; H Warnatz
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

7.  Transforming growth factor-beta and cellular immune responses in synovial fluids.

Authors:  M Lotz; J Kekow; D A Carson
Journal:  J Immunol       Date:  1990-06-01       Impact factor: 5.422

8.  Enumeration of T cell subsets and functional suppressor cell assays in patients with rheumatoid arthritis and HLA-B27-associated arthritis.

Authors:  G Lemm; H Warnatz
Journal:  Z Rheumatol       Date:  1984 May-Jun       Impact factor: 1.372

9.  The Fc receptor, FcRI, and other activation molecules on human mononuclear phagocytes after treatment with interferon-gamma.

Authors:  Y Jayaram; A M Buckle; N Hogg
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

10.  Cytokines in synovial fluid: II. The presence of tumour necrosis factor and interferon.

Authors:  S J Hopkins; A Meager
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

View more
  10 in total

1.  Dynamic secretome of bone marrow-derived stromal cells reveals a cardioprotective biochemical cocktail.

Authors:  David D Ellison; Yasir Suhail; Junaid Afzal; Laura Woo; Onur Kilic; Jeffrey Spees; Andre Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-25       Impact factor: 11.205

2.  Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease.

Authors:  J A van Roon; C M Verhoef; J L van Roy; F H Gmelig-Meyling; O Huber-Bruning; F P Lafeber; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1997-11       Impact factor: 19.103

3.  Oral administration of gammalinolenic acid, an unsaturated fatty acid with anti-inflammatory properties, modulates interleukin-1beta production by human monocytes.

Authors:  Robert K Furse; Ronald G Rossetti; Christina M Seiler; Robert B Zurier
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

4.  Psychosocial adaptation and cellular immunity in breast cancer patients in the weeks after surgery: An exploratory study.

Authors:  Bonnie B Blomberg; Juan P Alvarez; Alain Diaz; Maria G Romero; Suzanne C Lechner; Charles S Carver; Heather Holley; Michael H Antoni
Journal:  J Psychosom Res       Date:  2009-09-24       Impact factor: 3.006

5.  Increased production of a Th2 cytokine profile by activated whole blood cells from rheumatoid arthritis patients.

Authors:  A Haddad; J Bienvenu; P Miossec
Journal:  J Clin Immunol       Date:  1998-11       Impact factor: 8.317

6.  Variations in serum sCD23 in conditions with either enhanced humoral or cell-mediated immunity.

Authors:  A S Bansal; W Ollier; M N Marsh; R S Pumphrey; P B Wilson
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

7.  The anti-inflammatory actions of methotrexate are critically dependent upon the production of reactive oxygen species.

Authors:  Darren C Phillips; Kevin J Woollard; Helen R Griffiths
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

8.  Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity.

Authors:  Melanie Schirmer; Sanne P Smeekens; Hera Vlamakis; Martin Jaeger; Marije Oosting; Eric A Franzosa; Rob Ter Horst; Trees Jansen; Liesbeth Jacobs; Marc Jan Bonder; Alexander Kurilshikov; Jingyuan Fu; Leo A B Joosten; Alexandra Zhernakova; Curtis Huttenhower; Cisca Wijmenga; Mihai G Netea; Ramnik J Xavier
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

9.  Detection of serum soluble markers of immune activation in rheumatoid arthritis.

Authors:  T Kogure; T Itoh; Y Shimada; T Shintani; H Ochiai; K Terasawa
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

10.  Treatment with Tumor Necrosis Factor-α Inhibitors, History of Allergy, and Hypercalcemia Are Risk Factors of Immune Reconstitution Inflammatory Syndrome in HIV-Negative Pulmonary Tuberculosis Patients.

Authors:  Yoshimasa Hachisu; Yasuhiko Koga; Shu Kasama; Kyoichi Kaira; Masakiyo Yatomi; Haruka Aoki-Saito; Hiroaki Tsurumaki; Yosuke Kamide; Noriaki Sunaga; Toshitaka Maeno; Tamotsu Ishizuka; Takeshi Hisada
Journal:  J Clin Med       Date:  2019-12-30       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.